As U.S. Bids to Renew Relations With Havana, Heralded Cuban Diabetes Drug Off Limits
The developer of the medication, the Center for Genetic Engineering and Biotechnology in Havana, is forbidden to bring a nine-year-old drug, called Heberprot-P, to the United States for clinical trials and use.